{"href":"http://player.captivate.fm/services/oembed?url=http%3A%2F%2Fplayer.captivate.fm%2Fepisode%2Fd3d90fe4-06c4-4448-bb58-60d946081993","version":"1.0","provider_name":"Captivate.FM","provider_url":"https://www.captivate.fm","width":600,"height":200,"type":"rich","html":"","title":"What Devicemakers Need to Know about the FDA Pre-submission Process (Part Two)","description":"FDA Pre-submissions: They're a hot, timely topic.\n\nWe had a recent episode on the pre-submission process, but because there is so much to know, we decided to have our expert speaker, Mike Drues, back to make sure our listeners have the information necessary to properly deal with the FDA.\n\nRegulatory non-compliance is one of the biggest risks that medical device companies face, and it\u2019s so important to have a good rapport with the FDA and any other relevant regulatory agencies. \n\nMike Drues is the president of Vascular Sciences. He\u2019s an expert on regulatory topics, as he works with all different types of medical device companies in addition to working with the FDA and other regulatory bodies.\n\nSome of the topics that we discuss today include:\n- Why the pre-submission process has become such a hot topic.\n- The mechanics of the submission process.\n- The content of the pre-submission meeting and what questions should be answered.\n- Why you should not have expectations as to how long the process will take.\n- How early in the pre-development process you should contact the FDA.\n- Why the majority of submissions are rejected.\n- How this process can help you get through changes made post-submission.","thumbnail_width":300,"thumbnail_height":300,"thumbnail_url":"https://artwork.captivate.fm/f972d25c-e804-4f95-97bb-32d35f59e125/c80fb3fe-fe49-454b-aa12-5aab8229fafb.jpg"}